Seeing Is Believing
Currently out of the existing stock ratings of William Tanner, 46 are a BUY (76.67%), 12 are a HOLD (20%), 2 are a SELL (3.33%).
Analyst William Tanner, carries an average stock price target met ratio of 67.01% that have a potential upside of 37.1% achieved within 767 days. Previously, William Tanner worked at CANTOR FITZGERALD, GUGGENHEIM, B. RILEY.
William Tanner’s has documented 125 price targets and ratings displayed on 17 stocks. The coverage was on Healthcare, Financial Services sectors.
Most recent stock forecast was given on NVAX, Novavax at 22-Jul-2021.
Analyst best performing recommendations are on SUPN (SUPERNUS PHARMACEUTICALS).
The best stock recommendation documented was for PRTA (PROTHENA PLC) at 4/24/2018. The price target of $14 was fulfilled within 10 days with a profit of $2.91 (26.24%) receiving and performance score of 26.24.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Aug-2025
$16
$3.25 (25.49%)
$16
5 months 21 days ago
(21-Apr-2026)
2/4 (50%)
$7.51 (88.46%)
154
Buy Since 23-Feb-2024
$16
$7.12 (80.18%)
$22
11 months 2 days ago
(10-Nov-2025)
13/39 (33.33%)
$8.89 (125.04%)
100
Hold Since 13-May-2024
$7
$-1.88 (-21.17%)
$8
11 months 8 days ago
(04-Nov-2025)
3/3 (100%)
$-0.51 (-6.79%)
59
Hold Since 14-Jun-2024
$7
$-1.88 (-21.17%)
$9
1 years 1 months 22 days ago
(20-Aug-2025)
6/8 (75%)
$-1.74 (-19.91%)
186
Sell Since 17-Jun-2025
$6
$-2.88 (-32.43%)
1 years 3 months 25 days ago
(17-Jun-2025)
0/1 (0%)
$-0.49 (-7.55%)